A Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults

NCT02289820 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

363

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus (RSV)

Interventions

BIOLOGICAL: MEDI7510
BIOLOGICAL: IIV

Sponsor

MedImmune LLC